Hemostemix Inc. (CVE:HEM – Get Free Report)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.05 and traded as high as C$0.06. Hemostemix shares last traded at C$0.05, with a volume of 45,000 shares changing hands.
Hemostemix Stock Performance
The business’s 50 day moving average price is C$0.05 and its 200-day moving average price is C$0.06. The company has a market cap of C$4.36 million, a price-to-earnings ratio of -1.67 and a beta of 0.62.
Hemostemix Company Profile
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States.
Further Reading
- Five stocks we like better than Hemostemix
- Are Penny Stocks a Good Fit for Your Portfolio?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- What is the Euro STOXX 50 Index?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- What is MarketRank™? How to Use it
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
